Sodium Phosphates Injection, Solution
Product Images NDC 0409-7391

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Phosphates (NDC 0409-7391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Sodium Phosphates 01)

FDA Label Image

Principal Display Panel (15 mL Vial Label)

This is a description of a medication called Sodium Phosphates Injection, USP, which comes in a single-dose form of 15mL. It is an intravenous medication that must be diluted before use. The medication is manufactured by Hospira, Inc, located in Lake Forest, USA. Each milliliter of the medication contains monobasic sodium phosphate and ibasicsodium phosphate. The medication is sterile and non-pyrogenic. The dosage must be determined by a medical professional and is available in the insert. The medication has no more than 180 micrograms of aluminum per liter.*

FDA Label Image

Principal Display Panel (15 mL Vial Tray)

This text is describing a Sodium Phosphates Injection, which is intended for intravenous use. It contains monobasic and dibasic sodium phosphate compounds, is sterile, nonpyrogenic, and 15 mL is the usual dosage. It is important to check the insert for specific usage instructions. The pH is 5.5, and the injection is 7mOsmol/mL. Unfortunately, there is some unreadable or jumbled text, but this is the useful information that can be obtained from the given text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.